(Q41315190)

29 September 2017

1 reference

title

Mechanism of action of topoisomerase II-targeted antineoplastic drugs (English)

1 reference

29 September 2017

Osheroff N

1

1 reference

29 September 2017

Corbett AH

series ordinal

2

1 reference

29 September 2017

Robinson MJ

series ordinal

3

1 reference

29 September 2017

publication date

1 January 1994

1 reference

29 September 2017

published in

Advances in Pharmacology

1 reference

29 September 2017

volume

29B

1 reference

29 September 2017

page(s)

105-126

1 reference

Strand specificity of the topoisomerase II mediated double-stranded DNA cleavage reaction.

29 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Illegitimate recombination mediated by calf thymus DNA topoisomerase II in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Use of in vitro topoisomerase II assays for studying quinolone antibacterial agents

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

In situ localization of DNA topoisomerase II, a major polypeptide component of the Drosophila nuclear matrix fraction

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Expression of a mutant DNA topoisomerase II in CCRF-CEM human leukemic cells selected for resistance to teniposide

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Local sequence requirements for DNA cleavage by mammalian topoisomerase II in the presence of doxorubicin.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

When good enzymes go bad: conversion of topoisomerase II to a cellular toxin by antineoplastic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

DNA topoisomerases and models of sister-chromatid exchange

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

DNA topoisomerase II mutant of Saccharomyces cerevisiae: topoisomerase II is required for segregation of daughter molecules at the termination of DNA replication

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

DNA topoisomerases from rat liver: physiological variations

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Localization of topoisomerase II in mitotic chromosomes

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Topoisomerase II is a structural component of mitotic chromosome scaffolds.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Drug features that contribute to the activity of quinolones against mammalian topoisomerase II and cultured cells: correlation between enhancement of enzyme-mediated DNA cleavage in vitro and cytotoxic potential

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Ciprofloxacin and the fluoroquinolones. New concepts on the mechanism of action and resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Pattern of recognition of DNA by mammalian DNA topoisomerase II.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Uncoupling the DNA cleavage and religation activities of topoisomerase II with a single-stranded nucleic acid substrate: evidence for an active enzyme-cleaved DNA intermediate

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

The organisation of chromatin loops: characterization of a scaffold attachment site.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Metaphase chromosome structure. Involvement of topoisomerase II

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Nalidixic acid resistance: A second genetic character involved in DNA gyrase activity

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Inhibitory effects of quinolone antibacterial agents on eucaryotic topoisomerases and related test systems

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Yeast DNA topoisomerase II is encoded by a single-copy, essential gene

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Novel quinolone resistance mutations of the Escherichia coli DNA gyrase A protein: enzymatic analysis of the mutant proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Topoisomerase II: A specific marker for cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme-DNA complex

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Human DNA topoisomerase II: evaluation of enzyme activity in normal and neoplastic tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

DNA topoisomerase II is required at the time of mitosis in yeast

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Fluoroquinolone antimicrobial agents

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Inhibitory effects of quinolones on DNA gyrase of Escherichia coli and topoisomerase II of fetal calf thymus

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Significance of the methyl group on the oxazine ring of ofloxacin derivatives in the inhibition of bacterial and mammalian type II topoisomerases

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Drosophila topoisomerase II-DNA interactions are affected by DNA structure

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

ATP-dependent DNA topoisonmerase from D. melanogaster reversibly catenates duplex DNA rings

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Bacteriophage T4 DNA topoisomerase is the target of antitumor agent 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) in T4-infected Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Mutational alteration of the breakage/resealing subunit of bacteriophage T4 DNA topoisomerase confers resistance to antitumor agent m-AMSA.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Effect of 4-quinolones and novobiocin on calf thymus DNA polymerase alpha primase complex, topoisomerases I and II, and growth of mammalian lymphoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Induction of calf thymus topoisomerase II-mediated DNA breakage by the antibacterial isothiazoloquinolones A-65281 and A-65282

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Two independent amsacrine-resistant human myeloid leukemia cell lines share an identical point mutation in the 170 kDa form of human topoisomerase II

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Proteolysis patterns of epitopically labeled yeast DNA topoisomerase II suggest an allosteric transition in the enzyme induced by ATP binding

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

DNA topoisomerase poisons as antitumor drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Isolation of intercalator-dependent protein-linked DNA strand cleavage activity from cell nuclei and identification as topoisomerase II

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Inhibitory effects of quinolones on pro- and eucaryotic DNA topoisomerases I and II.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Mechanism of antitumor drug action: poisoning of mammalian DNA topoisomerase II on DNA by 4'-(9-acridinylamino)-methanesulfon-m-anisidide

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Effects of fleroxacin on HeLa cell functions and topoisomerase II

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Role of the divalent cation in topoisomerase II mediated reactions.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Biochemical basis for the interactions of type I and type II topoisomerases with DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Effect of antineoplastic agents on the DNA cleavage/religation reaction of eukaryotic topoisomerase II: inhibition of DNA religation by etoposide.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Calcium-promoted DNA cleavage by eukaryotic topoisomerase II: trapping the covalent enzyme-DNA complex in an active form.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Catalytic function of DNA topoisomerase II.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Effects of DNA intercalating agents on topoisomerase II induced DNA strand cleavage in isolated mammalian cell nuclei

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Effects of the DNA intercalators 4'-(9-acridinylamino)methanesulfon-m-anisidide and 2-methyl-9-hydroxyellipticinium on topoisomerase II mediated DNA strand cleavage and strand passage

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Local base sequence preferences for DNA cleavage by mammalian topoisomerase II in the presence of amsacrine or teniposide.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

DNA gyrase: structure and function.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

In vivo stimulation by antitumor drugs of the topoisomerase II induced cleavage sites in c-myc protooncogene

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Stabilization of the topoisomerase II-DNA cleavage complex by antineoplastic drugs: inhibition of enzyme-mediated DNA religation by 4'-(9-acridinylamino)methanesulfon-m-anisidide.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Effects of antineoplastic drugs on the post-strand-passage DNA cleavage/religation equilibrium of topoisomerase II.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Effects of novel fluoroquinolones on the catalytic activities of eukaryotic topoisomerase II: Influence of the C-8 fluorine group

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

The capture of a DNA double helix by an ATP-dependent protein clamp: a key step in DNA transport by type II DNA topoisomerases

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Segregation of recombined chromosomes in meiosis I requires DNA topoisomerase II.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Protein-associated DNA breaks in cells treated with adriamycin or ellipticine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Qualitative and quantitative aspects of intercalator-induced DNA strand breaks

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Drosophila topoisomerase II double-strand DNA cleavage: analysis of DNA sequence homology at the cleavage site

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Purification and characterization of DNA topoisomerase II from calf thymus associated with polypeptides of 175 and 150 kDa.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Stimulation of topoisomerase II mediated DNA cleavage at specific sequence elements by the 2-nitroimidazole Ro 15-0216.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Mechanism of action of nalidixic acid: Purification of Escherichia coli nalA gene product and its relationship to DNA gyrase and a novel nicking-closing enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Biochemical characteristics and physiological significance of major DNA topoisomerases

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Characterization of the interaction between topoisomerase II and DNA by transcriptional footprinting

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Mitotic spindle pulls but fails to separate chromosomes in type II DNA topoisomerase mutants: uncoordinated mitosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

DNA topoisomerase II is required for condensation and separation of mitotic chromosomes in S. pombe

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

1 reference

7 January 2021

The role of DNA topoisomerases in recombination and genome stability: a double-edged sword?

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

DNA Modification and Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Structure of the Drosophila DNA topoisomerase II gene. Nucleotide sequence and homology among topoisomerases II.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Nalidixic acid-resistant mutations of the gyrB gene of Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Induction of mammalian topoisomerase II dependent DNA cleavage by nonintercalative flavonoids, genistein and orobol

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Quinolone resistance-determining region in the DNA gyrase gyrB gene of Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Double-stranded DNA cleavage/religation reaction of eukaryotic topoisomerase II: evidence for a nicked DNA intermediate

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Microbial DNA topoisomerases and their inhibition by antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Protein-associated deoxyribonucleic acid strand breaks in L1210 cells treated with the deoxyribonucleic acid intercalating agents 4'-(9-acridinylamino) methanesulfon-m-anisidide and adriamycin

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

Cross-resistance of an amsacrine-resistant human leukemia line to topoisomerase II reactive DNA intercalating agents. Evidence for two topoisomerase II directed drug actions

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961134-5

7 January 2021

10.1016/S1054-3589(08)61134-5

Identifiers

DOI

0 references

1 reference